PubMed

Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.

Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR, Faxon DP, Cashin-Hemphill L, Sanmarco ME, French WJ, Shook TL, Gaarder TD, Mehra AO, Rabbani R, Sevanian A, Shil AB, Torres M, Vogelbach KH, Selzer RH; Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group.

N Engl J Med. 2003 Aug 7;349(6):535-45.PMID: 12904518 [PubMed - indexed for MEDLINE]Related articlesFree article

The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.

Pitt B, O'Neill B, Feldman R, Ferrari R, Schwartz L, Mudra H, Bass T, Pepine C, Texter M, Haber H, Uprichard A, Cashin-Hemphill L, Lees RS; QUIET Study Group.

Am J Cardiol. 2001 May 1;87(9):1058-63.PMID: 11348602 [PubMed - indexed for MEDLINE]Related articles

Low-density lipoprotein apheresis therapy during pregnancy.

Cashin-Hemphill L, Noone M, Abbott JF, Waksmonski CA, Lees RS.

Am J Cardiol. 2000 Nov 15;86(10):1160, A10.PMID: 11074223 [PubMed - indexed for MEDLINE]Related articles

Non-pharmacological lowering of low-density lipoprotein by apheresis and surgical techniques.

Lees RS, Cashin-Hemphill L, Lees AM.

Curr Opin Lipidol. 1999 Dec;10(6):575-9. Review.PMID: 10680051 [PubMed - indexed for MEDLINE]Related articles

Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial.

Cashin-Hemphill L, Holmvang G, Chan RC, Pitt B, Dinsmore RE, Lees RS.

Am J Cardiol. 1999 Jan 1;83(1):43-7.PMID: 10073783 [PubMed - indexed for MEDLINE]Related articles

Hormone-replacement therapy compared with simvastatin for postmenopausal women with hypercholesterolemia.

Cashin-Hemphill L, Vailas LI.

N Engl J Med. 1998 Jan 1;338(1):63; author reply 64. No abstract available. PMID: 9424570 [PubMed - indexed for MEDLINE]Related articles

Baseline clinical and angiographic data in the Quinapril Ischemic Event (QUIET) Trial.

Lees RS, Pitt B, Chan RC, Holmvang G, Dinsmore RE, Campbell LW, Haber HE, Klibaner MI, Cashin-Hemphill L.

Am J Cardiol. 1996 Nov 1;78(9):1011-6.PMID: 8916480 [PubMed - indexed for MEDLINE]Related articles

Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study.

Azen SP, Mack WJ, Cashin-Hemphill L, LaBree L, Shircore AM, Selzer RH, Blankenhorn DH, Hodis HN.

Circulation. 1996 Jan 1;93(1):34-41.PMID: 8616937 [PubMed - indexed for MEDLINE]Related articlesFree article

Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis.

Hodis HN, Mack WJ, LaBree L, Cashin-Hemphill L, Sevanian A, Johnson R, Azen SP.

JAMA. 1995 Jun 21;273(23):1849-54.PMID: 7776501 [PubMed - indexed for MEDLINE]Related articles

Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).

Alaupovic P, Hodis HN, Knight-Gibson C, Mack WJ, LaBree L, Cashin-Hemphill L, Corder CN, Kramsch DM, Blankenhorn DH.

Arterioscler Thromb. 1994 Dec;14(12):1906-13.PMID: 7981178 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of coronary atherosclerosis.

Hodis HN, Cashin-Hemphill L, Mack WJ.

Heart Dis Stroke. 1994 Jul-Aug;3(4):182-7. Review. No abstract available. PMID: 7921660 [PubMed - indexed for MEDLINE]Related articles

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin-Hemphill L, Hodis HN, DeBoer LW, Mahrer PR, Masteller MJ, Vailas LI, Alaupovic P, Hirsch LJ; MARS Research Group.

Ann Intern Med. 1993 Nov 15;119(10):969-76.PMID: 8214993 [PubMed - indexed for MEDLINE]Related articlesFree article

Femoral and coronary angiographic trials.

Cashin-Hemphill L.

Am J Cardiol. 1993 Feb 25;71(6):20B-25B. Review.PMID: 8434557 [PubMed - indexed for MEDLINE]Related articles

The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.

Cashin-Hemphill L, Kramsch DM, Azen SP, DeMets D, DeBoer LW, Hwang I, Vailas L, Hirsch LJ, Mack WJ, DeBoer L, et al.

Online J Curr Clin Trials. 1992 Oct 23;Doc No 26:[9897 words; 83 paragraphs]. Erratum in: Online J Curr Clin Trials 1992 Nov 14;Doc No 29:[85 words; 2. PMID: 1343613 [PubMed - indexed for MEDLINE]Related articles

Evaluation of human panelists in assessing coronary atherosclerosis.

Azen SP, Cashin-Hemphill L, Pogoda J, Mack WJ, Sanmarco ME, Wickham E, Blankenhorn DH.

Arterioscler Thromb. 1991 Mar-Apr;11(2):385-94.PMID: 1998656 [PubMed - indexed for MEDLINE]Related articlesFree article

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up.

Cashin-Hemphill L, Mack WJ, Pogoda JM, Sanmarco ME, Azen SP, Blankenhorn DH.

JAMA. 1990 Dec 19;264(23):3013-7.PMID: 2243429 [PubMed - indexed for MEDLINE]Related articles

Alterations in serum thyroid hormonal indices with colestipol-niacin therapy.

Cashin-Hemphill L, Spencer CA, Nicoloff JT, Blankenhorn DH, Nessim SA, Chin HP, Lee NA.

Ann Intern Med. 1987 Sep;107(3):324-9.PMID: 3113309 [PubMed - indexed for MEDLINE]Related articles

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L.

JAMA. 1987 Jun 19;257(23):3233-40. Erratum in: JAMA 1988 May 13;259(18):2698. PMID: 3295315 [PubMed - indexed for MEDLINE]Related articles